文献速递放射性药物与辐射防护

验证2-18F-氟脱氧山梨醇作为潜在放射性药物用于肺部细菌感染显像

Validation of 2-18F-Fluorodeoxysorbitol as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung.
PubMed 文献 · J Nucl Med · 2017-08-28

研究在滴注活或死肺炎克雷伯菌的小鼠中比较18F-FDS与18F-FDG PET/CT显像肺部感染与炎症。18F-FDS与18F-FDG均可追踪感染程度,最低检出限为10^7细菌,但18F-FDS区分肺炎克雷伯菌肺部感染与肺部炎症的特异性高于18F-FDG。

要点

  • 18F-FDS与18F-FDG的肺部摄取均可用于追踪BLI测得的细菌感染程度。
  • 最低检出限为10^7细菌。
  • 18F-FDS区分肺炎克雷伯菌肺部感染与肺部炎症的特异性高于18F-FDG。

核心结论

  • 18F-FDS与18F-FDG在感染肺的摄取均可用于追踪BLI测得的细菌感染程度,最低检出限为10^7细菌。
  • 18F-FDS区分肺炎克雷伯菌肺部感染与肺部炎症的特异性高于18F-FDG。

研究设计与样本

  • 研究将白色C57雌性小鼠经气管内接种活或死肺炎克雷伯菌,分别诱导肺部感染或肺部炎症。
  • 一组小鼠用于监测疾病进展,接种后第0、1、2、3天分别使用18F-FDS或18F-FDG行PET/CT(每种示踪剂n=12)。
  • 另一组先经生物发光成像(BLI)筛选,仅选择可见感染(感兴趣区>10^8 ph/s)的小鼠用18F-FDS行PET/CT(n=12)。
  • 炎症组从接种后第1天至第4天分别使用18F-FDS或18F-FDG行PET/CT,每种示踪剂各5只小鼠。

主要发现

  • 疾病进展研究中,BLI显示接种后第2天出现明显肺部感染,第3天感染显著加重。
  • 接种前基线显像CT未见局灶性肺实变,两种PET示踪剂在肺部摄取均低。
  • 第2天CT识别出肺实变区域,两种PET示踪剂对应摄取较基线增加2.5倍。
  • 第3天CT见广泛斑片状肺实变,18F-FDS和18F-FDG摄取均大幅增加(分别为9.2和3.9)。
  • PET与BLI研究显示18F-FDG摄取与菌落形成单位呈边缘相关(r=0.63),而18F-FDS相关性更好(r=0.85)。

关键数值与推荐

  • 第3天感染肺与炎症肺的摄取比值:18F-FDS为8.5,18F-FDG为1.7。
  • 18F-FDS与18F-FDG的最低细菌检出限为10^7细菌。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

2-18F-fluorodeoxysorbitol (18F-FDS) has been shown to be a promising agent with high selectivity and sensitivity in imaging bacterial infection. The objective of our study was to validate 18F-FDS as a potential radiopharmaceutical for imaging bacterial infection longitudinally in the lung. Methods: Albino C57 female mice were intratracheally inoculated with either live or dead Klebsiella pneumoniae to induce either lung infection or lung inflammation. One group of mice was imaged to monitor disease progression. PET/CT was performed on days 0, 1, 2, and 3 after inoculation using either 18F-FDS or 18F-FDG (n = 12 for each tracer). The other group was first screened by bioluminescent imaging (BLI) to select only mice with visible infection (region of interest > 108 ph/s) for PET/CT imaging with 18F-FDS (n = 12). For the inflammation group, 5 mice each were imaged with PET/CT using either 18F-FDS or 18F-FDG from days 1 to 4 after inoculation. Results: For studies of disease progression, BLI showed noticeable lung infection on day 2 after inoculation and significantly greater infection on day 3. Baseline imaging before inoculation showed no focal areas of lung consolidation on CT and low uptake in the lung for both PET radiotracers. On day 2, an area of lung consolidation was identified on CT, with a corresponding 2.5-fold increase over baseline for both PET radiotracers. On day 3, widespread areas of patchy lung consolidation were found on CT, with a drastic increase in uptake for both 18F-FDS and 18F-FDG (9.2 and 3.9). PET and BLI studies showed a marginal correlation between 18F-FDG uptake and colony-forming units (r = 0.63) but a much better correlation for 18F-FDS (r = 0.85). The uptake ratio of infected lung over inflamed lung was 8.5 and 1.7 for 18F-FDS and 18F-FDG on day 3. Conclusion: Uptake of both 18F-FDS and 18F-FDG in infected lung could be used to track the degree of bacterial infection measured by BLI, with a minimum detection limit of 107 bacteria. 18F-FDS, however, is more specific than 18F-FDG in differentiating K. pneumoniae lung infection from lung inflammation.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Li J, Zheng H, Fodah R, et al. Validation of 2-18F-Fluorodeoxysorbitol as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung. J Nucl Med. 2017. PMID: 28848037. doi:10.2967/jnumed.117.195420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。